Compassionate Access with reference to Tuberculosis

India is battling multidrug-resistant TB, with about 2.5% of all new TB cases in the country being resistant to Rifampicin, or to both Rifampicin and isoniazid – the two most commonly used anti-TB drugs. At the end of 2015, India had 79,000 cases of drug-resistant TB, 11% more than in 2014.Bedaquiline drug can be an […]

New BCG-based TB vaccine-VPM1002

Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. Tuberculosis infection can be of two kinds-latent and active. Latent tuberculosis is not contagious and do not show any symptoms since the bacterium remains inactive in the body. Latent tuberculosis can become active tuberculosis in those people who have weak immune system especially in […]